Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...
Slower gait speed, but not handgrip strength or muscle mass, is associated with an increased risk for cardiovascular outcomes ...
Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart ...
Adrenomed is utilizing ADM as a biomarker to guide Adrecizumab ... endothelial barrier integrity plays a role, such as acute heart failure. Sepsis is a complex disorder or syndrome that presents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results